We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PCYN market cap is 1.54M. The company's latest EPS is USD -0.0385 and P/E is -4.94.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.33M | 4.72M | 4.84M | 4.69M | 4.98M |
| Operating Income | 153k | 325k | -237k | -97k | -232k |
| Net Income | 95k | 751k | -227k | -67k | -313k |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.82M | 4.24M | 3.8M | 3.56M | 3.2M |
| Total Liabilities | 658k | 1.29M | 1.13M | 946k | 917k |
| Total Equity | 2.16M | 2.95M | 2.67M | 2.62M | 2.29M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 199k | 280k | -230k | 146k | -61k |
| Investing | -24k | 480k | -83k | -455k | -64k |
| Financing | 201k | -199k | -154k | N/A | N/A |
| Market Cap | 1.54M |
| Price to Earnings Ratio | -4.94 |
| Price to Sales Ratio | 0.31 |
| Price to Cash Ratio | 4.74 |
| Price to Book Ratio | 0.67 |
| Dividend Yield | - |
| Shares Outstanding | 8.12M |
| Average Volume (1 week) | 14.32k |
| Average Volume (1 Month) | 35.22k |
| 52 Week Change | 10.84% |
| 52 Week High | 0.338 |
| 52 Week Low | 0.17 |
| Spread (Intraday) | 0.09 (36.13%) |
| Company Name | Procyon Corp (PK) |
| Address |
4380 s syracuse street denver, colorado 80237-2625 |
| Website | https://procyoncorp.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
